Allergy diagnosis
Diagnostic products for prick testing, intradermal venom testing and beta-lactam allergy evaluation in professional practice.
Allergy diagnosis & molecular immunotherapy
DIATER
Biopharmaceutical solutions spanning allergy diagnosis and allergen immunotherapy, developed for specialist-led patient pathways.
From identifying the allergen to personalised treatment.
DIATER develops and manufactures products for allergy diagnosis and treatment. Its diagnostic portfolio supports specialist investigation through approaches including prick testing, intradermal testing and professional evaluation of beta-lactam allergy.
The immunotherapy portfolio spans subcutaneous, intradermal and sublingual pathways, including molecular immunotherapy developed around purified native allergens.
Molecular immunotherapy
A precision approach based on purified native allergens and specialist selection of the relevant treatment pathway.
Treatment formats
Subcutaneous, intradermal and sublingual immunotherapy options developed for different clinical and patient needs.
DIATER diagnostic and immunotherapy products require qualified professional assessment, prescribing or administration as applicable. Availability, indications and regulatory status vary by market.
Diagnosis to treatment
A specialist allergy pathway.
Official DIATER imagery representing professional skin testing and allergen immunotherapy.
DIATER at a glance
Questions about the portfolio.
What does DIATER develop?
DIATER develops products for specialist allergy diagnosis and allergen immunotherapy, including molecular immunotherapy based on purified native allergens.
Can patients choose a DIATER treatment from this website?
No. Diagnosis, treatment selection and prescribing or administration require qualified professional assessment. Product availability, indications and regulatory status vary by market.
DIATER enquiries